郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands.

期刊：The Journal of pharmacy and pharmacology发表年份：2006作者：Marcello Leopoldo; Enza Lacivita; Nicola A Colabufo; Francesco Berardi; Roberto Perrone
阅读更多 →

药效评价[D-1-Nal4]endomorphin-2 is a potent micro-opioid receptor antagonist in the aequorin luminescence-based calcium assay.

期刊：Life sciences发表年份：2006作者：Jakub Fichna; Mariola Piestrzeniewicz; Katarzyna Gach; Jeroen Poels; Emmanuel Burgeon; Jozef Vanden Broeck; Anna Janecka
阅读更多 →

药效评价4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

期刊：Journal of medicinal chemistry发表年份：2006作者：Ombretta Lenzi; Vittoria Colotta; Daniela Catarzi; Flavia Varano; Guido Filacchioni; Claudia Martini; Letizia Trincavelli; Osele Ciampi; Katia Varani; Federico Marighetti; Erika Morizzo; Stefano Moro
阅读更多 →

药效评价Interaction of riluzole with the closed inactivated state of Kv4.3 channels.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2006作者：Hye Sook Ahn; Sung Eun Kim; Hyun-Jong Jang; Myung-Jun Kim; Duck-Joo Rhie; Shin-Hee Yoon; Yang-Hyeok Jo; Myung-Suk Kim; Ki-Wug Sung; Sang June Hahn
阅读更多 →